Login
Subscribe
Opinion: Coronavirus and Regulating Access to High-Risk Pathogens
Opinion: Coronavirus and Regulating Access to High-Risk Pathogens
Overbearing restrictions on research into toxins and pathogens such as SARS-CoV-2 could undermine public health and security in the long run.
Overbearing restrictions on research into toxins and pathogens such as SARS-CoV-2 could undermine public health and security in the long run.
regulation, opinion
Opinion: Emergency Use Authorizations Are a Threat to Science
Kevin J. Tracey and Christina Brennan | Dec 1, 2020 | 4 min read
As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.
Opinion: Ethical Boundaries Needed on the Uses of Synthetic DNA
John D. Loike and Robert Pollack | Mar 1, 2019 | 4 min read
A newly expanded genetic alphabet that includes four synthetic nucleotides highlights the need for strict boundaries on their use.
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Cecile Janssens | Mar 19, 2018 | 3 min read
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
Opinion: No Objections to Nano?
Susanna Priest | Feb 3, 2012 | 4 min read
While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
Opinion: Celebrities Pushing Drugs?
Howard Brody | Jan 30, 2012 | 4 min read
Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.
Opinion: Sustainable Drug Monitoring
Jur Strobos and Andy Stergachis | Aug 31, 2011 | 3 min read
Pharmacovigilance must keep pace with global distribution of drugs in resource-limited settings.